Spruce Needle Polyprenols Protect Against Atorvastatin-Induced Muscle Weakness and do not Influence Central Nervous System Functions in Rats
Open accessAbstract
Polyprenols (PPs) have been identified in almost all living organisms. The richest source of PPs is the needles of conifer trees. Endogenously, PPs, similarly to cholesterol, are synthesised in human and animal cells via the mevalonate pathway. Previous studies have demonstrated the anti-oxidant properties of PPs. To our knowledge, no studies have been published on the influence of PPs on muscle strength. We hypothesised that administration of PPs could prevent changes in muscle functioning caused by statins (weakness, etc.). In the present study, atorvastatin (80 mg/kg) was used as a model compound. PPs at doses 1, 10 and 20 mg/kg were administered. Both drugs were given per os for 16 days. The influence of atorvastatin, PPs and their combination on behaviour, muscle strength, plasma cholesterol and creatine kinase activity was assessed in female Wistar rats. Our data demonstrated that atorvastatin considerably impaired muscle strength, whereas PPs protected that effect. Neither PPs, nor atorvastatin influenced plasma cholesterol levels, whereas PPs at dose 20 mg/kg elevated creatine kinase activity by about 25%. PPs at the tested doses did not alter behaviour, indicating safety of central nervous system functions. The obtained data suggest usefulness of PPs as a complement in statin therapy to reduce muscle-related side effects.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Creatine kinase is a biomarker for myopathy and muscle breakdown.
“to estimate the plasma level of creatine kinase (CK) as a biomarker for myopathy and muscle breakdown (Jansone et al. 2016)”
From Can coenzyme Q10 alleviate the toxic effect of fenofibrate on skeletal muscle? (2023) · cites this paper as Jansone et al. 2016
Cites
Mevalonate pathway: A review of clinical and therapeutical implications
Buhaescu, I., & Izzedine, H. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2007.03.016 · Cited by 620 · see citing works
An assessment by the statin muscle safety task force: 2014 update
Rosenson, R. S., Baker, S. K., Jacobson, T. A., Kopecky, S. L., & Parker, B. A. (2014) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2014.03.004 · Cited by 485 · see citing works
Statin‐Associated Memory Loss: Analysis of 60 Case Reports and Review of the Literature
Wagstaff, L. R., Mitton, M. W., McLendon-Arvik, B., & Doraiswamy, P. M. (2003) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.7.871.32720 · Cited by 365 · see citing works
The biological role of dolichol
Chojnacki, T., & Dallner, G. (1988) · Biochemical Journal · doi:10.1042/bj2510001 · Cited by 300 · see citing works
Statins: Mechanisms of neuroprotection
van der Most, P. J., Dolga, A. M., Nijholt, I. M., Luiten, P. G. M., & Eisel, U. L. M. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.02.002 · Cited by 268 · see citing works
Statin Safety: An Overview and Assessment of the Data—2005
Bays, H. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.006 · Cited by 264 · see citing works
Sierra, S., Ramos, M. C., Molina, P., Esteo, C., Vázquez, J. A., & Burgos, J. S. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101179 · Cited by 248 · see citing works
Desai, R. J., Rothman, K. J., Bateman, B. T., Hernández–Dı́az, S., & Huybrechts, K. F. (2016) · Epidemiology · doi:10.1097/ede.0000000000000595 · Cited by 246 · see citing works
miRNA as molecular target of polyphenols underlying their biological effects
Milenković, D., Jude, B., & Morand, C. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.046 · Cited by 218 · see citing works
Intolerance to Statins: Mechanisms and Management
Bitzur, R., Cohen, H., Kamari, Y., & Harats, D. (2013) · Diabetes Care · doi:10.2337/dcs13-2038 · Cited by 178 · see citing works
Sathasivam, S., & Lecky, B. R. F. (2008) · BMJ · doi:10.1136/bmj.a2286 · Cited by 164 · see citing works
Molecular clues into the pathogenesis of statin‐mediated muscle toxicity
Baker, S. K. (2005) · Muscle & Nerve · doi:10.1002/mus.20291 · Cited by 139 · see citing works
Hartley, M. D., & Imperiali, B. (2011) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2011.10.018 · Cited by 129 · see citing works
Frank, R. E. (2009) · PubMed · Cited by 120 · see citing works
Polyisoprenoids – Secondary metabolites or physiologically important superlipids?
Surmacz, L., & Świeżewska, E. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.03.059 · Cited by 108 · see citing works
Islam, M. S. (2011) · Phytomedicine · doi:10.1016/j.phymed.2011.06.025 · Cited by 107 · see citing works
From glycosylation disorders to dolichol biosynthesis defects: a new class of metabolic diseases
Cantagrel, V., & Lefeber, D. J. (2011) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-011-9301-0 · Cited by 91 · see citing works
Werner, M., Sacher, J., & HOHENEGGER, M. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705928 · Cited by 76 · see citing works
Tuccori, M., Montagnani, S., Mantarro, S., Capogrosso-Sansone, A., Ruggiero, E., Saporiti, A., Antonioli, L., Fornai, M., & Blandizzi, C. (2014) · CNS Drugs · doi:10.1007/s40263-013-0135-1 · Cited by 58 · see citing works
Rhabdomyolysis secondary to lovastatin therapy
Manoukian, A., Bhagavan, N. V., Hayashi, T., Nestor, T. A., Rios, C., & Scottolini, A. G. (1990) · Clinical Chemistry · doi:10.1093/clinchem/36.12.2145 · Cited by 56 · see citing works
Overcoming toxicity and side-effects of lipid-lowering therapies
Wilkinson, M. J., Laffin, L. J., & Davidson, M. H. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.01.006 · Cited by 56 · see citing works
Experimental evaluation of analgesic and anti-inflammatory activity of simvastatin and atorvastatin
Sontakke, S. D., & Jaiswal, S. (2012) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.99311 · Cited by 51 · see citing works
Ballard, K. D., Parker, B. A., Capizzi, J. A., Grimaldi, A. S., Clarkson, P. M., Cole, S. M., Keadle, J., Chipkin, S. R., Pescatello, L. S., Simpson, K., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.07.001 · Cited by 42 · see citing works
Antinociception induced by atorvastatin in different pain models
García, G. G., Miranda, H. F., Noriega, V., Sierralta, F., Olavarría, L., Zepeda, R. J., & Prieto, J. C. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.08.007 · Cited by 38 · see citing works
Statin or fibrate chronic treatment modifies the proteomic profile of rat skeletal muscle
Camerino, G. M., Pellegrino, M. A., Brocca, L., Digennaro, C., Camerino, D. C., Pierno, S., & Bottinelli, R. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.01.022 · Cited by 37 · see citing works
The uptake of dietary polyprenols and their modification to active dolichols by the rat liver.
Chojnacki, T., & Dallner, G. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33138-7 · Cited by 34 · see citing works
Wang, C., He, L., Yan, M., Zheng, G., & Liu, X. (2014) · AGE · doi:10.1007/s11357-014-9676-6 · Cited by 33 · see citing works
The guinea pig as a preclinical model for demonstrating the efficacy and safety of statins
Madsen, C. S., Janovitz, E., Zhang, R., Nguyen-Tran, V., Ryan, C. S., Yin, X., Monshizadegan, H., Chang, M., D’Arienzo, C., Scheer, S., et al. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.131615 · Cited by 33 · see citing works
Plant Polyisoprenoids and Control of Cholesterol Level
Pronin, A. V., Danilov, L. L., Narovlyansky, A. N., & Av, S. (2013) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-013-0253-y · Cited by 29 · see citing works
New perspectives for (S)-dolichol and (S)-nordolichol synthesis and biological functions
Bizzarri, R., Cerbai, B., Signori, F., Solaro, R., Bergamini, E., Tamburini, I., & Chiellini, E. (2003) · Biogerontology · doi:10.1023/b:bgen.0000006555.87407.04 · Cited by 25 · see citing works
Fedotova, J., Soultanov, V., Nikitina, T. V., Roschin, V., & Ordayn, N. (2012) · Phytomedicine · doi:10.1016/j.phymed.2011.09.073 · Cited by 23 · see citing works
Comparison of the frequency of adverse events in patients treated with atorvastatin or simvastatin
Abourjaily, H. M., Alsheikh-Ali, A. A. A., & Karas, R. H. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00124-3 · Cited by 23 · see citing works
Elbaset, M. A., Safar, M. M., Mahmoud, S. S., Negm, S. A., & Agha, A. M. (2014) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2013-0430 · Cited by 21 · see citing works
Uptake and modification of dietary polyprenols and dolichols in rat liver
Jakobsson, Å., Świeżewska, E., Chojnacki, T., & Dallner, G. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)81055-5 · Cited by 13 · see citing works
Федотова, Ю. О., Султанов, В. С., Кузнецова, Н. Н., Рощин, В. И., & Nikitina, T. V. (2010) · PubMed · Cited by 9 · see citing works
Atorvastatin and simvastatin as analgesic agents in experimental models
Dwajani, S., Kumar, V. H., & Keerthi, D. (2012) · Journal of Basic and Clinical Pharmacy · doi:10.4103/0976-0105.105334 · Cited by 7 · see citing works
STOMPing forward: Statins, muscle complaints and CK
Laaksonen, R. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.07.044 · Cited by 6 · see citing works
Soner, C. (2013) · African Journal of Pharmacy and Pharmacology · doi:10.5897/ajpp12.983 · Cited by 5 · see citing works
Studies on Seperation of Polyprenols from leaves of Ginkgo biloba L. by Molecular Short Distillation
Xi-zhuan, C. (2008) · Linchan huaxue yu gongye · Cited by 1 · see citing works
Flagged first, then by citations
1 of the 40 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Dhir, N., Jain, A., Sharma, A. R., Prakash, A., Radotra, B., & Medhi, B. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01183-w · Cited by 37 · see citing works
Bakhtiari, M., Ghasemi, N., Salehi, H., Amirpour, N., Kazemi, M., & Mardani, M. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119812 · Cited by 21 · see citing works
Vanaga, I., Gubernator, J., Nakurte, I., Kletnieks, U., Muceniece, R., & Jansone, B. (2020) · Molecules · doi:10.3390/molecules25081801 · Cited by 13 · see citing works
Self-citationZaman, B., Mostafa, I., Hassan, T., Ahmed, S., Esha, N. J. I., Chowdhury, F. A., Bosu, T., Chowdhury, H. N., Mallick, A., Islam, M. S., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116438 · Cited by 12 · see citing works
Dhir, N., Jain, A., Sharma, A. R., Sharma, S., Mahendru, D., Patial, A., Malik, D., Prakash, A., Attri, S. V., Bhattacharyya, S., et al. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114471 · Cited by 9 · see citing works
Olopade, F. E., Femi-Akinlosotu, O. M., Adekanmbi, A. J., Ajani, S., & Shokunbi, M. T. (2020) · Anatomical Science International · doi:10.1007/s12565-020-00561-z · Cited by 9 · see citing works
Adebiyi, O. E., Adigun, K. O., Folarin, O. R., Olopade, J. O., & Olayemi, F. O. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112650 · Cited by 8 · see citing works
Yuan, H., Zhang, C., Zhou, P., Yang, X., Tao, R., Ye, J., & Wang, C. (2023) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2023.104679 · Cited by 8 · see citing works
Osuntokun, O. S., Ademinkanra, A. J., Atere, T. G., Olayiwola, G., Adedokun, K. I., & Adekomi, D. A. (2020) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2020.107484 · Cited by 7 · see citing works
Rahdar, S., Basir, Z., Tabandeh, M. R., Ghotbeddin, Z., & Khazaeel, K. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03381-4 · Cited by 6 · see citing works
Onukak, C. E., Femi-Akinlosotu, O. M., Obasa, A. A., Folarin, O. R., Ajibade, T. O., Igado, O. O., Esan, O. O., Oyagbemi, T. O., Adeogun, A. V., Oyagbemi, A. A., et al. (2025) · BMC Neuroscience · doi:10.1186/s12868-025-00943-x · Cited by 3 · see citing works
Yuan, H., Zhang, C., Wang, Y., Zhou, H., Zhao, J. F., & Wang, C. (2025) · Industrial Crops and Products · doi:10.1016/j.indcrop.2025.120563 · Cited by 2 · see citing works
Ezzahra, K. F., Soumia, E.-D., Habiba, N., Laila, I.-D., Mhamed, R., Hicham, B., Fatima-Zahra, A., & Samira, B. (2025) · Developmental Neurobiology · doi:10.1002/dneu.22990 · Cited by 2 · see citing works
Eltarzy, M. A., Rabie, M. A., Sayed, R. H., Ahmed, M. A. E., & Ahmedy, O. A. (2026) · Drug Development Research · doi:10.1002/ddr.70238 · Cited by 2 · see citing works
Regulatory roles of eugenol in paraquat-altered SNCA/LZTS3/MAPT in the cerebellum of Wistar rats
Uchewa, O. O., Ibegbu, A. O., Okoronkwo, O. S., Nwafor, J. A., & Egwu, O. A. (2025) · Laboratory Animal Research · doi:10.1186/s42826-025-00236-8 · Cited by 2 · see citing works
Oyadeyi, A., Ajao, F. O., Babalola, K. T., & Mustapha, Y. (2021) · Nigerian Journal of Physiological Sciences · doi:10.54548/nigerjphysiolsci.v36i2.5 · Cited by 1 · see citing works
Can coenzyme Q10 alleviate the toxic effect of fenofibrate on skeletal muscle?
El-Bassouny, D. R., Mansour, A. A., Ellakkany, A. S., Ayuob, N. N., & AbdElfattah, A. A. (2023) · Histochemistry and Cell Biology · doi:10.1007/s00418-023-02205-5
Polyprenol Liposomes Improve the Efficiency of Oxygen Usage in Well-Trained Amateur Athletes
Ušacka, L., Plakane, L., Vanaga, I., Klētnieks, K., Jansone, B., Muceniece, R., Klētnieks, U., & Pahirko, L. (2022) · Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences · doi:10.2478/prolas-2022-0009
Self-citationConference Programme and Book of Abstracts
Bartkienė, E., Zokaitytė, E., Lėlė, V., Starkutė, V., Zavistanavičiūtė, P., Klupšaitė, D., Černauskas, D., Ružauskas, M., Bartkevičs, V., Pugajeva, I., et al. (2020) · doi:10.22364/icnh.3.2020
Neuroprotective Effect of Coffee and Tea on Haloperidol-InducedParkinson's Disease in Rat Model
Saad, S. E. A., Mohammed, Z. M., Amara, I. E. A., Aburas, K. M., & Abrahem, A. (2022) · Libyan Journal of Medical Research · doi:10.54361/ljmr.16207
Abi, I., Matthias, S. O., & Saater, E. M. (2024) · Journal of African Association of Physiological Sciences · doi:10.4314/jaaps.v11i2.1
Franklin, Z. G., Djiogue, S., Sandrine, M. N. Y., Awounfack, C. F., Tadah, R. N. D., Pieme, C. A., & Njamen, D. (2025) · Exploration of Drug Science · doi:10.37349/eds.2025.1008127
Anjum, S., & Jahan, N. (2026) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v16i7.7885
- Authors
- Jansone, B., Dzirkale, Z., Jekabsons, K., Pilipenko, V., Beitnere, U., Māgure, I., Skumbiņš, R., Klētnieks, U., Vanaga, I., Muceniece, R., & Kluša, V.
- Affiliations
- University of Latvia (LV)
- Faculty of Medicine, University of Latvia, Raiņa bulv. 19, Rīga, LV-1586, LATVIA
- Silvanols Ltd., Kurbada iela 2A, Rīga, LV-1009, LATVIA
- Pharma and Chemistry Competence Centre of Latvia Ltd., Dzirnavu iela 93-27, Rīga, LV-1006, LATVIA
- Corresponding author
- Jansone, Baiba
- Venue
- Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.
- Publisher
- Walter de Gruyter GmbH
- Published
- 2016-02-01
- Volume
- 70
- Issue
- 1
- Pages
- 13-20
- ISSN
- 1407-009X (ISSN-L)
- OpenAlex
- W2322198581
- Cited by
- 23
- References
- 40
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 3 · 2023: 4 · 2022: 2 · 2021: 2 · 2020: 5
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- Locations
- Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences (publishedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- European Regional Development Fund
- Topics
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
- Health Sciences › Medicine › Surgery › Natural Products and Biological Research
- Keywords
- polyprenols, spruce needles, atorvastatin, statin-induced myopathy, muscle weakness, muscle strength, creatine kinase, serum cholesterol, mevalonate pathway, antioxidant activity, statin adverse effects
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
